Relationship between Bone Mineral Density and Fragility Fracture

Abstract

Background: Reduced bone density is a major risk factor for fragility fracture. Previous studies reported, that 69% to 100% of patients with fragility fractures had low bone mineral density (BMD). Objective: The objective of the study is to estimate the prevalence of osteoporosis and osteopenia among patients with fragility fractures. Results: The result of the study revealed that the mean age of patients included in the study was 65.11 ± 10.17 and the majority (77.3%) were females. The most common sites of fractures were the femur, radius and vertebra (30.7%, 17.0% and 14.8% respectively). Moreover, more than 95% of patients with fragility fracture who underwent BMD testing had low bone mineral density. In female with fragility fracture the prevalence of osteoporosis was higher in comparison to male (58.8% and 45.0% respectively). Conclusion: Our data showed that low BMD measurement is prevalent in patient with fragility fracture. It also highlighted the importance of implementation of Fracture liaison service, to reduce the gap between fragility fracture and osteoporosis treatment.

Share and Cite:

Alshaali, A. , Abdelaziz, S. , Aljaziri, A. , Farid, T. , Sobhy, M. , Hammam, M. and Gamil, M. (2024) Relationship between Bone Mineral Density and Fragility Fracture. Open Journal of Orthopedics, 14, 470-477. doi: 10.4236/ojo.2024.1411043.

1. Introduction

Fragility fracture is defined as a fracture sustained from a fall from standing height or less. Its most common cause is osteoporosis. The fracture is both a sign and a symptom of osteoporosis. Typical fractures in patients with osteoporosis include vertebral, proximal femur, distal forearm and proximal humerus [1] [2]. These fractures are associated with an increased morbidity and mortality in elderly patients, and place a high economic burden on health care systems. Moreover, a previous fragility fracture doubles the risk of subsequent fractures [3] [4].

Previous studies have shown that, low bone mineral density (BMD) is the main important determinant of fragility fractures [4] [5]. and this could be evaluated using the dual-energy X-ray absorptiometry (DEXA) measurements. The BMD measurements are a powerful predictor of the risk of fragility [6], this risk increases with decreasing BMD. Many studies have shown that, fragility fracture risk will increase by one-to-three times if BMD reduced by one standard deviation [7] [8].

Despite the magnitude of risk imparted by a history of fracture, the great majority of patients who present with fragility fractures are not evaluated with DEXA scan and are not considered for osteoporosis treatment. It has been reported that less than 20% of those who sustain a fragility fracture receive therapies to reduce the risk of fracture within the year following the fracture [9].

A Japanese study, included 1445 patients with a fracture of the distal end of the radius [10] reported that after the fracture, bone density was measured in only 126 patients (8.7%) and treatment for osteoporosis was performed in only 193 patients. (13.4%)

According to The Gulf Cooperation Council (GCC) countries report, women aged 65 and above with a prior fragility fracture can be considered for treatment without the need for further assessment. The BMD measurement is more appropriate in younger postmenopausal women. Nevertheless, it is recommended by many experts to have baseline BMD for all patients with fragility fracture to follow progress of therapy [11].

A fracture liaison service (FLS) is a comprehensive care, multi- and interdisciplinary intervention designed to reduce subsequent fracture risk in patients who recently sustained fragility fracture. Fracture Liaison Service is a special program designed to identify, investigate, and initiate appropriate treatment for patients presenting with fragility fracture [10]. Fracture liaison service is a secondary fracture prevention program that is led by a coordinator (liaison). A fracture liaison service follow patients sustaining fragility fractures and/or osteoporotic fractures from the time of injury presentation until care is transitioned to the primary care provider. It is an interdisciplinary team includes orthopaedic surgery, primary care, osteoporosis expert and ancillary services like physical therapy and dietician to ensure that patients are properly assessed and managed [12] [13].

A Fracture Liaison Service was implemented in Dubai health in February 2023. It aims to screen patient aged 50 and above with fragility fracture for osteoporosis and provide appropriate assessment and management to reduce the risk of subsequent fracture. Patients who were admitted in Trauma centre in Rashid hospital with fragility fracture were referred to osteoporosis clinic in primary health care. The FLS coordinator contact the patient, explain the service and then book the appointment. Patient will then do DEXA scan and BMD will be measured.

Based on the new FLS implemented in Dubai health, the purpose of this paper is to understand relationship between bone mineral density and fragility fracture, as well as the prevalence of osteoporosis and osteopenia in among patients with fragility fracture.

2. Methodology

This study was conducted in the osteoporosis clinics in the primary healthcare from February December 2023. The study included 88 patients who met the following inclusion criteria: patients aged 50 years or more with a recent fragility fracture referred through fracture liaison service. Patients who refused osteoporosis clinic appointment and DEXA scan were not included in the study (Figure 1).

Figure 1. Patient journey in FLS.

2.1. Data Collection

Data were collected from patients’ electronic health records and fracture liaison service registry. The following variables were studied: epidemiological variables (age, sex, nationality), clinical variables (vitamin D, calcium, creatinine, site of fracture), radiological variables (Lumbar T score and femur T score).

2.2. BMD Measurement

The BMD of the hip and the lumbar spine was measured using dual energy X-ray absorptiometry (Lunar, GE Health Care) and the result was expressed as BMD, T-score and Z score and. The reference standard of a T-score is the peak bone density, as reached in men or women between 20 - 30 years of age. The T-score is then defined as the number of standard deviations from this score. According to the WHO definition, “osteoporosis” is defined as a T-score equal to or lower than −2.5, “osteopenia” is defined as a T-score between −2.5 and −1.0, and when the T-score is equal to greater than −1.0 BMD is “normal” [14].

2.3. Ethical Consideration

The procedures used were approved by the Research Ethics Committee (Medical Research Committee, Dubai Health Authority, Dubai, UAE-MBRU IRB-2023-324).

2.4. Data Analysis

Data collected were analyzed using the SPSS version 20 for the descriptive statistics of the demographic characteristics of the patient. Chi-square test was used to compare the patients with regard to the qualitative variables. Fisher exact test was used when cell counts less than 5. P value < 0.05 was considered statistically significant with 95% confidence interval.

3. Results

Table 1 summarizes the characteristics of the patients referred in FLS. The total number of patients included in the study was 88. The mean age was 65.11 ± 10.17 and more than one third (34.8%) aged 70 - 79. The majority (77.3%) were female and 56.8% of patients were UAE national.

Table 1. Characteristics of the patients referred in FLS.

Age

50 - 59

18 (20.2%)

60 - 69

24 (27.0%)

70 - 79

31 (34.8%)

≥80

16 (18.0%

mean age

65.11 ± 10.17

Sex

Male

20 (22.7%)

Female

68 (77.3%)

Nationality

UAE

50 (56.8%)

GCC

5 (5.7%)

Expat

33 (37.5%)

Table 2 summarizes the lab investigation results of patients referred in FLS. Overall out of 88 patients, 60.2% (n = 53) of patients had vitamin D deficiency and 21.6% (n = 19) of patients had hypocalcemia. Moreover, 30.7% (n = 27) had renal impairment.

Table 2. Distribution of patients according to Lab investigation result.

Lab investigation

Normal

Low

vitamin d

35 (39.8%)

53 (60.2%)

calcium

69(78.4%)

19 (21.6%)

Normal

High

creatinine

61 (69.3%)

27 (30.7%)

Table 3 reveals the result of DEXA scan of patients referred through FLS, more than 50% of the patients were found to have osteoporosis and more than 40% were osteopenia.

Table 3. Distribution of patients according to DEXA result.

Diagnosis

Number

Percentage

Normal

1

1.1

Osteopenia

38

43.2

Osteoporosis

49

55.7

Table 4 shows the site of fracture in patients referred through FLS. The most common sites of fractures were the femur, radius and vertebra (30.7%, 17.0% and 14.8% respectively).

Table 4. Distribution of patients according to site of fracture.

Site of fracture

Number

Percentage

Vertebrae

13

14.8

Femur

27

30.7

Pelvis

5

5.6

Tibia

3

3.4

Fibula

1

1.1

Patella

4

4.5

Ankle

6

6.8

Shoulder

2

2.3

Humerus

8

9.1

Radius

15

17.0

Ulna

1

1.1

Elbow

3

3.4

Females referred in FLS had higher percentage of osteoporosis in comparison to male (58.8% vs 94.5). The difference was statistically non-significant (Table 5).

Table 5. Distribution of Bone mineral density according to sex.

Bone mineral density

P value

Normal

Osteopenia

Osteoporosis

Female

1(1.5%)

27 (39.4%)

40 (58.8%)

NS

Male

0 (0%)

11(55.0%)

9(45.0%)

4. Discussion

Reduced bone density is a major risk factor for fragility fracture. Because of increased bone loss after the menopause in women, the prevalence of osteoporosis increases markedly with age, from 2% at 50 years to more than 25% at 80 years in women. Moreover, it’s reported that the longevity of the population increases, and therefore osteoporosis and fragility fracture will increase [15].

Bone mineral density decline and the incidence for most fractures increases after menopause in women and with advanced age in men. Previous studies have demonstrated that bone density is an important predictor of fracture risk [16]. It was reported that 69% to 100% of patients with fragility fractures who underwent BMD testing across 20 intervention studies had low BMD [16] [17]. This is in congruent with our study which showed that almost all of the patient with fragility fracture had low bone mineral density.

In the United Arab Emirates, it was reported that there are 2.25 osteoporosis hip fractures per 1000 population per year. The femur fractures are life-threatening due to the long period of bed immobilization and the high risk of complication [18]. Our study showed that, the most common fragility fracture was femur fracture. If such fracture is recognized and osteoporosis treated, the risk of a future fracture can be reduced, preventing the downward spiral in health and quality of life that often follows hip fracture.

Globally, women at a higher risk of osteoporotic fracture in comparison to men, one in three women and one in five men over the age of 50 will suffer an osteoporotic fracture [6]. This could be explained that women have thinner bone that men and they tend to lose bone at younger age in comparison to men. Similarly, our study showed that, female had more fragility fracture and higher percentage of female were referred through FLS in comparisons to male.

Moreover, our study showed that among female with fragility fracture, the prevalence of osteoporosis was higher than osteopenia, 58.8% and 39.4% respectively. However, among male with fragility fracture the prevalence of osteopenia was higher than osteoporosis (45% and 55% respectively). This suggests that osteoporosis is more common in female with fragility fractures than in male.

In our study, we observed that the 60% of patients referred through FLS had vitamin D deficiency. Vitamin D deficiency has been documented to increase fracture risk. Bone turnover is increased and accelerated bone loss occurs in elderly with Vitamin D deficiency. Moreover, it has been observed that these patients experience muscle weakness and therefore at increased risk for falls [19].

5. Limitation of the Study

This study didn’t include other risk factors associated with fragility fracture, such as comorbidities, medications and previous family history of fracture. It didn’t include bone turnover markers related to bone metabolism.

6. Conclusion

In conclusion, this study showed that more than 95% of patients with fragility fracture who underwent BMD testing had low bone mineral density. It highlights the importance of implementation of FLS, to reduce the gap between fragility fracture and osteoporosis treatment.

Author Contribution

All authors have been directly involved with the various aspects of the study. We attest to the fact that all authors have participated in the research, read the manuscript, attest to the validity and legitimacy of the data.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] Kanis, J.A., Oden, A., Johnell, O., Jonsson, B., de Laet, C. and Dawson, A. (2001) The Burden of Osteoporotic Fractures: A Method for Setting Intervention Thresholds. Osteoporosis International, 12, 417-427.
https://doi.org/10.1007/s001980170112
[2] Migliorini, F., Giorgino, R., Hildebrand, F., Spiezia, F., Peretti, G.M., Alessandri-Bonetti, M., et al. (2021) Fragility Fractures: Risk Factors and Management in the Elderly. Medicina, 57, Article 1119.
https://doi.org/10.3390/medicina57101119
[3] Shuid, A.N., Khaithir, T.M.N., Mokhtar, S.A. and Mohamed, I.N. (2014) A Systematic Review of the Outcomes Of osteoporotic Fracture Patients after Hospital Discharge: Morbidity, Subsequent Fractures, And mortality. Therapeutics and Clinical Risk Management, 10, 937-948.
https://doi.org/10.2147/tcrm.s72456
[4] Cummings, S.R., Browner, W., Cummings, S.R., Black, D.M., Nevitt, M.C., Browner, W., et al. (1993) Bone Density at Various Sites for Prediction of Hip Fractures. The Lancet, 341, 72-75.
https://doi.org/10.1016/0140-6736(93)92555-8
[5] Leslie, W.D., Metge, C. and Ward, L. (2003) Contribution of Clinical Risk Factors to Bone Density-Based Absolute Fracture Risk Assessment in Postmenopausal Women. Osteoporosis International, 14, 334-338.
https://doi.org/10.1007/s00198-003-1375-6
[6] Nuti, R., Brandi, M.L., Checchia, G., Di Munno, O., Dominguez, L., Falaschi, P., et al. (2018) Guidelines for the Management of Osteoporosis and Fragility Fractures. Internal and Emergency Medicine, 14, 85-102.
https://doi.org/10.1007/s11739-018-1874-2
[7] Johnell, O., Kanis, J.A., Oden, A., Johansson, H., De Laet, C., Delmas, P., et al. (2005) Predictive Value of BMD for Hip and Other Fractures. Journal of Bone and Mineral Research, 20, 1185-1194.
https://doi.org/10.1359/jbmr.050304
[8] Marshall, D., Johnell, O. and Wedel, H. (1996) Meta-analysis of How Well Measures of Bone Mineral Density Predict Occurrence of Osteoporotic Fractures. BMJ, 312, 1254-1259.
https://doi.org/10.1136/bmj.312.7041.1254
[9] Kanis, J.A., Svedbom, A., Harvey, N. and McCloskey, E.V. (2014) The Osteoporosis Treatment Gap. Journal of Bone and Mineral Research, 29, 1926-1928.
https://doi.org/10.1002/jbmr.2301
[10] Baba, T., Hagino, H., Nonomiya, H., Ikuta, T., Shoda, E., Mogami, A., et al. (2015) Inadequate Management for Secondary Fracture Prevention in Patients with Distal Radius Fracture by Trauma Surgeons. Osteoporosis International, 26, 1959-1963.
https://doi.org/10.1007/s00198-015-3103-4
[11] Al-Saleh, Y., Al-Daghri, N.M., Sabico, S., Alessa, T., Al Emadi, S., Alawadi, F., et al. (2020) Diagnosis and Management of Osteoporosis in Postmenopausal Women in Gulf Cooperation Council (GCC) Countries: Consensus Statement of the GCC Countries’ Osteoporosis Societies under the Auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Archives of Osteoporosis, 15, Article No. 109.
https://doi.org/10.1007/s11657-020-00778-5
[12] Kates, S.L. and Miclau, T. (2022) The Fracture Liaison Service: Its History, Current State, How It Works, and Future Directions. OTA International: The Open Access Journal of Orthopaedic Trauma, 5, e192.
https://doi.org/10.1097/oi9.0000000000000192
[13] Nakayama, A., Major, G., Holliday, E., Attia, J. and Bogduk, N. (2015) Evidence of Effectiveness of a Fracture Liaison Service to Reduce the Re-Fracture Rate. Osteoporosis International, 27, 873-879.
https://doi.org/10.1007/s00198-015-3443-0
[14] Sheu, A. and Diamond, T. (2016) Bone Mineral Density: Testing for Osteoporosis. Australian Prescriber, 39, 35-39.
https://doi.org/10.18773/austprescr.2016.020
[15] National Institute for Health and Care Excellence (NICE (2017) Osteoporosis: Assessing the Risk of Fragility Fracture.
[16] Posen, J., Beaton, D.E., Sale, J. and Bogoch, E.R. (2013) Bone Mineral Density Testing after Fragility Fracture: Informative Test Results Likely. Canadian Family Physician, 59, e564-E571.
[17] Johnell, O., Gullberg, B., Kanis, J.A., et al. (1995) Risk Factors for Hip Fracture in European Women: The MEDOS Study. Journal of Bone and Mineral Research, 10, 1802-1815. Cummings, S.R., Black, D.M., Nevitt, M.C., et al. (1993) Bone Density at Various Sites for Prediction of Hip Fractures. The Study of Osteoporotic Fractures Research Group. Lancet, 341, 72-77.
[18] United Arab Emirates International Osteoporosis Foundation (2011) The Middle East & Africa Regional Audit—Epidemiology, Costs & Burden of Osteoporosis in 2011.
[19] Bischoff-Ferrari, H.A., Dawson-Hughes, B., Willett, W.C., Staehelin, H.B., Bazemore, M.G., Zee, R.Y., et al. (2004) Effect of Vitamin D on Falls: A Meta-Analysis. JAMA, 291, 1999-2006.
https://doi.org/10.1001/jama.291.16.1999

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.